ethyl [(5-nitro-1,3-thiazol-2-yl)amino](oxo)acetate, 95.0%, 1g

6-Chloro-1-(4-methoxyphenyl)-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole hydrochloride, 98%, 1g

tert-Butyl (3S,4S)-4-(aminomethyl)-3-hydroxypiperidine-1-carboxylate, 98%, 10g

Buffer solution pH 12.00 ±0.05 (20 °C), ROTI®Calipure ready to use, 1 l, plastic packaging.

1-(5-Bromo-2-iodophenyl)ethanone, 95+%, 5g

1-CHLORO-4-METHYLISOQUINOLINE, 95.0%, 5g

3-tert-Butylbenzaldehyde, 95.0%, 25g

2-(3,3,3-Trifluoropropylsulfanyl)pyridine, 5g

Methyl 5-bromo-3-chloro-2-methylbenzoate, 98%, 1g

5-(3-Nitrophenyl)furan-2-carbaldehyde, 95.0%, 1g

Cbz-L-isoleucine DCHA, 98.0%, 25g

3-Iodo-1-methyl-1h-pyrrolo[2,3-b]pyridine, 97%, 1g

4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide, 98%, 25g